The Filings Report

BrightSpring Health Services, Inc. Common Stock

BTSGNasdaqCIK 1865782Healthcare / Healthcare Providers & Servicesfiscal year ends December15 quarters since 2023

Revenue, Q3 FY2026
$4.2B
+26.4% on Q3 FY2025
Net income
$100M
+79.3% on Q3 FY2025
Free cash flow
$182M
+97.7% on Q3 FY2025
Diluted EPS
$0.45
+73.1% on Q3 FY2025
Revenue, TTM
$15.3B
trailing four quarters
Net margin, TTM
2.7%
net income $410M
Free cash flow, TTM
$492M
$603M less $110M capex
Cash and equivalents
$718M
long-term debt $2.1B, Sep 30, 2026
Shares, 12-month change
+10.3%
199M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$13.2B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, BrightSpring Health Services, Inc. Common Stock reported revenue of $4.2B, +26.4% on Q3 FY2025, and net income of $100M (+79.3%). Operating margin was 3.8%. Free cash flow, operating cash flow less capital expenditures, was $182M ($204M less $22M). Diluted earnings per share were $0.45.

The last 15 quarters

Q1 FY2023 to Q3 FY2026, through the filing of October 30, 2026.

Revenue and net incomeRevenueNet income
−$2B$0$2B$4B$6BQ1'23, Revenue: $2.0BQ1'23, Net income: −$21MQ1'23Q2'23, Revenue: $2.2BQ2'23, Net income: $4MQ2'23Q3'23, Revenue: $2.3BQ3'23, Net income: −$131MQ3'23Q4'23, Revenue: $1.2BQ4'23, Net income: −$7MQ4'23Q1'24, Revenue: $2.3BQ1'24, Net income: −$46MQ1'24Q2'24, Revenue: $2.4BQ2'24, Net income: $20MQ2'24Q3'24, Revenue: $2.6BQ3'24, Net income: −$8MQ3'24Q4'24, Revenue: $2.7BQ4'24, Net income: $16MQ4'24Q1'25, Revenue: $2.9BQ1'25, Net income: $30MQ1'25Q2'25, Revenue: $3.1BQ2'25, Net income: $28MQ2'25Q3'25, Revenue: $3.3BQ3'25, Net income: $56MQ3'25Q4'25, Revenue: $3.6BQ4'25, Net income: $77MQ4'25Q1'26, Revenue: $3.6BQ1'26, Net income: $149MQ1'26Q2'26, Revenue: $3.9BQ2'26, Net income: $84MQ2'26Q3'26, Revenue: $4.2BQ3'26, Net income: $100MQ3'26−$2B$0$2B$4B$6BQ1'23, Revenue: $2.0BQ1'23, Net income: −$21MQ1'23Q2'23, Revenue: $2.2BQ2'23, Net income: $4MQ3'23, Revenue: $2.3BQ3'23, Net income: −$131MQ3'23Q4'23, Revenue: $1.2BQ4'23, Net income: −$7MQ1'24, Revenue: $2.3BQ1'24, Net income: −$46MQ1'24Q2'24, Revenue: $2.4BQ2'24, Net income: $20MQ3'24, Revenue: $2.6BQ3'24, Net income: −$8MQ3'24Q4'24, Revenue: $2.7BQ4'24, Net income: $16MQ1'25, Revenue: $2.9BQ1'25, Net income: $30MQ1'25Q2'25, Revenue: $3.1BQ2'25, Net income: $28MQ3'25, Revenue: $3.3BQ3'25, Net income: $56MQ3'25Q4'25, Revenue: $3.6BQ4'25, Net income: $77MQ1'26, Revenue: $3.6BQ1'26, Net income: $149MQ1'26Q2'26, Revenue: $3.9BQ2'26, Net income: $84MQ3'26, Revenue: $4.2BQ3'26, Net income: $100MQ3'26

Net income losses drawn in red.

Free cash flow
−$200M−$100M$0$100M$200MQ1'23, Free cash flow: $22MQ1'23Q2'23, Free cash flow: −$46MQ2'23Q3'23, Free cash flow: $16MQ3'23Q4'23, Free cash flow: $146MQ4'23Q1'24, Free cash flow: −$101MQ1'24Q2'24, Free cash flow: −$39MQ2'24Q3'24, Free cash flow: $7MQ3'24Q4'24, Free cash flow: $75MQ4'24Q1'25, Free cash flow: $84MQ1'25Q2'25, Free cash flow: $25MQ2'25Q3'25, Free cash flow: $92MQ3'25Q4'25, Free cash flow: $194MQ4'25Q1'26, Free cash flow: $101MQ1'26Q2'26, Free cash flow: $15MQ2'26Q3'26, Free cash flow: $182MQ3'26−$200M−$100M$0$100M$200MQ1'23, Free cash flow: $22MQ1'23Q2'23, Free cash flow: −$46MQ3'23, Free cash flow: $16MQ3'23Q4'23, Free cash flow: $146MQ1'24, Free cash flow: −$101MQ1'24Q2'24, Free cash flow: −$39MQ3'24, Free cash flow: $7MQ3'24Q4'24, Free cash flow: $75MQ1'25, Free cash flow: $84MQ1'25Q2'25, Free cash flow: $25MQ3'25, Free cash flow: $92MQ3'25Q4'25, Free cash flow: $194MQ1'26, Free cash flow: $101MQ1'26Q2'26, Free cash flow: $15MQ3'26, Free cash flow: $182MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3B$4BQ1'23Q2'23Q3'23Q4'23, Cash and equivalents: $13MQ4'23, Long-term debt: $3.3BQ4'23Q1'24, Cash and equivalents: $58MQ1'24, Long-term debt: $2.5BQ1'24Q2'24, Cash and equivalents: $25MQ2'24, Long-term debt: $2.6BQ2'24Q3'24, Cash and equivalents: $36MQ3'24, Long-term debt: $2.6BQ3'24Q4'24, Cash and equivalents: $61MQ4'24, Long-term debt: $2.6BQ4'24Q1'25, Cash and equivalents: $52MQ1'25, Long-term debt: $2.5BQ1'25Q2'25, Cash and equivalents: $70MQ2'25, Long-term debt: $2.5BQ2'25Q3'25, Cash and equivalents: $140MQ3'25, Long-term debt: $2.5BQ3'25Q4'25, Cash and equivalents: $88MQ4'25, Long-term debt: $2.5BQ4'25Q1'26, Cash and equivalents: $889MQ1'26, Long-term debt: $2.4BQ1'26Q2'26, Cash and equivalents: $550MQ2'26, Long-term debt: $2.1BQ2'26Q3'26, Cash and equivalents: $718MQ3'26, Long-term debt: $2.1BQ3'26$0$1B$2B$3B$4BQ1'23Q3'23Q4'23, Cash and equivalents: $13MQ4'23, Long-term debt: $3.3BQ1'24, Cash and equivalents: $58MQ1'24, Long-term debt: $2.5BQ1'24Q2'24, Cash and equivalents: $25MQ2'24, Long-term debt: $2.6BQ3'24, Cash and equivalents: $36MQ3'24, Long-term debt: $2.6BQ3'24Q4'24, Cash and equivalents: $61MQ4'24, Long-term debt: $2.6BQ1'25, Cash and equivalents: $52MQ1'25, Long-term debt: $2.5BQ1'25Q2'25, Cash and equivalents: $70MQ2'25, Long-term debt: $2.5BQ3'25, Cash and equivalents: $140MQ3'25, Long-term debt: $2.5BQ3'25Q4'25, Cash and equivalents: $88MQ4'25, Long-term debt: $2.5BQ1'26, Cash and equivalents: $889MQ1'26, Long-term debt: $2.4BQ1'26Q2'26, Cash and equivalents: $550MQ2'26, Long-term debt: $2.1BQ3'26, Cash and equivalents: $718MQ3'26, Long-term debt: $2.1BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

BrightSpring Health Services, Inc. Common Stock income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Mar 6, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue4,2133,8733,6143,5513,3343,1482,8782,747+26.4%
Cost of revenue—————————
Gross profit519493482413392375338339+32.3%
Research and development—————————
Selling, general and administrative358362361304304326288283+17.7%
Operating income16013012110888495156+82.7%
Other income (expense)—————————
Pretax income129948370501099+160.9%
Income tax29792012105+136.3%
Net income100841497756283016+79.3%
Diluted EPS ($)0.450.380.67—0.260.130.14—+73.1%
Diluted shares (millions)220220221—218216215——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

BrightSpring Health Services, Inc. Common Stock balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Mar 6, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents71855088988140705261+411.5%
Short-term investments—————————
Total current assets2,7662,4702,6892,8942,7802,6482,5281,893−0.5%
Total assets6,2675,9866,2136,4136,0495,9445,8475,926+3.6%
Total current liabilities1,7111,5561,5481,8491,5501,5051,4581,428+10.4%
Long-term debt2,1472,1492,4452,4552,4652,4782,4892,562−12.9%
Total liabilities4,0813,9284,2234,5274,2284,1984,1564,275−3.5%
Stockholders’ equity2,1772,0491,9791,8751,8191,7431,6871,648+19.7%
Shares outstanding (millions)199198194194180177174175—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

BrightSpring Health Services, Inc. Common Stock cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Mar 6, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow204441232321084910291+89.3%
Capital expenditures2229223816241815+40.1%
Free cash flow (CFO − capex)1821510119492258475+97.7%
Depreciation and amortization3841394041424255−5.8%
Share repurchases06060————0—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 27, 2026.

Income statement

BrightSpring Health Services, Inc. Common Stock income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 27, 2026FY2024ended Dec 31, 2024filed Mar 6, 2025FY2023ended Dec 31, 2023filed May 2, 2024FY2022ended Dec 31, 2022filed Mar 6, 2025
Revenue12,91110,0727,6917,721
Cost of revenue————
Gross profit1,5181,2661,1391,354
Research and development————
Selling, general and administrative1,2231,1581,0811,126
Operating income29510858188
Other income (expense)————
Pretax income138(95)(214)(46)
Income tax33(26)(32)33
Net income191(18)(155)(54)
Diluted EPS ($)0.87(0.09)(1.31)(0.46)
Diluted shares (millions)220193118118

Balance sheet

BrightSpring Health Services, Inc. Common Stock balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 27, 2026FY2024ended Dec 31, 2024filed Mar 6, 2025FY2023ended Dec 31, 2023filed May 2, 2024FY2022ended Dec 31, 2022filed Mar 6, 2025
Cash and equivalents886113—
Short-term investments————
Total current assets2,8941,8931,457—
Total assets6,4135,9265,533—
Total current liabilities1,8491,4281,248—
Long-term debt2,4552,5623,332—
Total liabilities4,5274,2754,920—
Stockholders’ equity1,8751,648585—
Shares outstanding (millions)194175——

Cash flow statement

BrightSpring Health Services, Inc. Common Stock cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 27, 2026FY2024ended Dec 31, 2024filed Mar 6, 2025FY2023ended Dec 31, 2023filed May 2, 2024FY2022ended Dec 31, 2022filed Mar 6, 2025
Operating cash flow49024211(5)
Capital expenditures95817470
Free cash flow (CFO − capex)395(57)137(75)
Depreciation and amortization164204202204
Share repurchases4311—
Dividends paid————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$874K
1 sales by 1 insider; officers and directors $874K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$1.7B
11 sales by 7 insiders; officers and directors $32M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 25, 2026Rousseau Jon BSee Remarks, Directortax withholding36,355$60.11$2M1MOct 27, 2026
Sep 14, 2026Greenwell Scott A.President, PharMericaoption exercise11,973$22.27$267K46,345Sep 16, 2026
Sep 14, 2026Greenwell Scott A.President, PharMericaopen-market sale10b5-115,099$57.91$874K31,246Sep 16, 2026
Jul 25, 2026Rousseau Jon BSee Remarks, Directortax withholding56,319$72.91$4M1MJul 28, 2026
Jun 20, 2026Greenwell Scott A.President, PharMericatax withholding2,487$66.25$165K34,372Jun 22, 2026
Jun 11, 2026Shah Nigam H.Directoraward4,013$0.00—4,013Jun 12, 2026
Jun 5, 2026KKR Phoenix Aggregator L.P.+4 more10% owneropen-market saleindirect15M$58.45$857M27MJun 5, 2026
Jun 5, 2026KKR Phoenix Aggregator L.P.+4 more10% ownerotherindirect324,608$0.00—27MJun 5, 2026
Jun 5, 2026KKR Phoenix Aggregator L.P.+4 more10% ownergiftindirect36,927$0.00—0Jun 5, 2026
Jun 5, 2026KKR Phoenix Aggregator L.P.+4 more10% ownergiftindirect23,263$0.00—0Jun 5, 2026
Jun 5, 2026Rousseau Jon BSee Remarks, Directoroption exercise130,000$6.37$828K1MJun 5, 2026
Jun 5, 2026Rousseau Jon BSee Remarks, Directoropen-market sale130,000$58.75$8M1MJun 5, 2026
Jun 5, 2026Rousseau Jon BSee Remarks, Directoroption exerciseindirect130,000$6.37$828K130,000Jun 5, 2026
Jun 5, 2026Rousseau Jon BSee Remarks, Directoropen-market saleindirect130,000$58.75$8M0Jun 5, 2026
Jun 5, 2026Nalley Lisa ASee Remarksoption exercise35,000$6.37$223K166,948Jun 5, 2026
Jun 5, 2026Nalley Lisa ASee Remarksopen-market sale35,000$58.75$2M131,948Jun 5, 2026
Jun 5, 2026Phipps Jennifer AChief Financial Officeroption exercise35,000$6.37$223K285,224Jun 5, 2026
Jun 5, 2026Phipps Jennifer AChief Financial Officeropen-market sale35,000$58.75$2M250,224Jun 5, 2026
May 5, 2026Miller Steven BDirectoraward4,983$0.00—23,106May 7, 2026
May 5, 2026Kirtley Olivia FDirectoraward4,983$0.00—36,997May 7, 2026
May 5, 2026Wicks Timothy ADirectoraward4,983$0.00—25,504May 7, 2026
Apr 25, 2026Rousseau Jon BSee Remarks, Directortax withholding16,222$48.16$781K1MApr 28, 2026
Mar 30, 2026Barnes Robert AllenPresident, Community Livingtax withholding6,748$41.54$280K25,549Mar 31, 2026
Mar 5, 2026Greenwell Scott A.President, PharMericaaward20,020$0.00—36,859Mar 6, 2026
Mar 5, 2026Nalley Lisa ASee Remarksaward21,354$0.00—131,948Mar 6, 2026

Full insider history for BrightSpring Health Services, Inc. Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
BrightSpring Health Services, Inc., CIK 1865782 on EDGAR
Extract generated
November 4, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): not filed
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/BTSG.json